NTT Home Page
Opportunities
Products
Out Licensing
NTT pharmaceutical out-Licensing strategy
Category
Description
Projects/Programmes
A
Out-licensing of the Ethosome technology to large pharmaceutical firms to enhance their existing products
N/A
B
Out-licensing of formulations incorporating off-patent generic drugs or active ingredients with the Ethosome technology
Treatments for:
alopecia;
deep skin infection;
herpes;
hormone deficiencies;
inflammation;
post operative nausea; and
atopic dermatitis.
C
Late stage out-licensing of formulations incorporating off-patent generic drugs or active ingredients with the Ethosome technology
Erectile Dysfunction
NTT's out-licensing model is based on receiving down payments and milestone payments followed by royalties on sales.
Home
|
About Us
|
Technology
|
Opportunities
|
Investor Center
|
News
|
Site Map
|
Contact Us
Copyright © 2005 NTT NOVEL THERAPEUTIC TECHNOLOGIES. All rights reserved.
Created by
NETRON
